WITH recent concerns around the Strokecheck program being offered within Amcal pharmacies (PD 12 Jan, 27 Mar), Sigma has announced that it is pulling the program from Amcal stores, in spite of some early positive results for patients.
Sigma pointed out that the program was run by Strokecheck, an independent charity and not-for profit organisation, offering services by a qualified GP utilising the consulting suite of the pharmacy.
"Amcal remains committed to providing accessible care to the community to help entrench a collaborative and proactive approach to improving health management, and to provide referral pathways for patients to re-engage with GP's and the broader healthcare system," Sigma said.
The above article was sent to subscribers in Pharmacy Daily's issue from 31 Mar 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 31 Mar 17
